GTx, Inc. GTXI today announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 10:00 am ET in New York.
A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at http://www.gtxinc.com. A replay of the presentation will also be available and archived on the site for 30 days.
About GTx
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of medicines to treat serious and/or significant unmet medical conditions, including stress urinary incontinence and prostate cancer.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180531005164/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.